News Focus
News Focus
icon url

DewDiligence

05/07/12 10:17 AM

#141403 RE: dav1234 #141398

I give Tofacitinib a 75% chance to be endorsed by a solid plurality of the advisory panel (i.e. something better than a 7-5 or 8-7 vote in favor). Does anyone here agree/disagree?